🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trials studies how well pembrolizumab and vactosertib work af...
Status
Terminated
Location
University of California, San Francisco
Start Date
2019-07-22
Trial ID
NCT03844750
Treatments Being Tested
This study assesses the potential of using a TGFβ receptor inhibitor for th...
Status
Terminated
Location
Weill Medical College of Cornell University
Start Date
2019-11-22
Trial ID
NCT04103645
Treatments Being Tested
Participants in this study will receive 200 milligram (mg) TEW-7197 taken a...
Status
Completed
Location
Inje University Busan Paik Hospital
Start Date
2018-08-08
Trial ID
NCT03704675
Treatments Being Tested
MP-VAC-209 is a Phase I/II, open label, single arm, multi-center study to a...
Status
Recruiting
Location
UH Rainbow Babies & Children's Hospital
Start Date
2023-05-01
Trial ID
NCT05588648
Treatments Being Tested
This interventional clinical trial aims to find ways of improving treatment...
Status
Suspended
Location
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
2024-09-30
Trial ID
NCT06044311
Treatments Being Tested
The purpose of this study is to see if the study drug, called Vactosertib, ...
Status
Completed
Location
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
2017-07-21
Trial ID
NCT03143985
Treatments Being Tested
This is Phase 2, open label, multi-center study to assess safety and effica...
Status
Terminated
Location
Samsung Medical Center
Start Date
2020-12-17
Trial ID
NCT04515979
Treatments Being Tested
To determine recommended phase 2 dose and to evaluate the safety of vactose...
Status
Unknown
Location
Samsung Medical Center
Start Date
2021-04-19
Trial ID
NCT04258072
Treatments Being Tested
Vactosertib and imatinib combination in patients with advanced desmoid tumo...
Status
Withdrawn
Location
Yeonsei University Severance Hospital
Start Date
2021-06-01
Trial ID
NCT06219733
Treatments Being Tested
This is an open-label, multicenter study to assess the safety, tolerability...
Status
Completed
Location
National Cancer Center
Start Date
2018-12-20
Trial ID
NCT03724851
Treatments Being Tested